关于 "Sterol Lipids" 的结果39 个结果
- 11(Z),14(Z)-Eicosadienoic Acid methyl esterCAS: 61012-46-2
A more lipid soluble form of 11(Z),14(Z)-eicosadienoic acid
- Riboflavin TetrabutyrateCAS: 752-56-7
Riboflavin tetrabutyrate is a lipophilic flavin derivative with antioxidative and lipid peroxide-removing activity.
- Glucosamine (D-Glucosamine)CAS: 3416-24-8
Glucosamine (2-amino-2-deoxy-D-glucose) is an amino sugar and a prominent precursor in the biochemical synthesis of glycosylated proteins and lipids. It is commonly used as a treatment for osteoarthritis. Glucosamine(GS) treatment selectively downregulates HIF-1α at the protein level in YD-8 cells via interference of production of the citric acid cycle metabolites.
- Cor a 8.0101
Recombinant Non-specific Lipid-Transfer Protein Cor a 8 produced in SF9 is a glycosylated, polypeptide chain having a calculated molecular mass of 11kDa
- Tri a 14.0101
Recombinant Non-Specific Lipid-Transfer Protein Tri a 14 produced in SF9 is a glycosylated, polypeptide chain having a calculated molecular mass of 13kDa
- Rifamycin SCAS: 13553-79-2
Rifamycin S, a quinone and an antibiotic against Gram-positive bacteria (including MRSA), is a clinical drug used to treat tuberculosis and leprosy. Rifamycin S generates reactive oxygen species (ROS) and inhibits microsomal lipid peroxidation.
- Glycerophospho-N-Eicosapentaenoyl Ethanolamine
Precursor for eicosapentaenoyl ethanolamide
Immunology/Inflammation - SKI VCAS: 24418-86-8
SKI V is a noncompetitive and potent inhibitor of non-lipid sphingosine kinase with IC50 of 2 μM for GST-hSK. SKI-V also inhibits PI3K with IC50 of 6 μM for hPI3k. SKI-V decreases formation of the mitogenic second messenger sphingosine-1-phosphate (S1P) and induces apoptosis with antitumor activity.
- 7-keto Cholesterol-d7CAS: 127684-08-6
An internal standard for the quantification of 7-keto cholesterol
- AMP-DeoxynojirimycinCAS: 216758-20-2
Inhibitor of glucosylceramide synthase and non-lysosomal glucosylceramidase
| 货号 | 产品名称 | CAS号 | 靶点 / 通路 | 引用 | 结构 |
|---|---|---|---|---|---|
| GC41875 | 11(Z),14(Z)-Eicosadienoic Acid methyl ester | 61012-46-2 | Innate Immunity | ||
A more lipid soluble form of 11(Z),14(Z)-eicosadienoic acid | |||||
| GC37531 | Riboflavin Tetrabutyrate | 752-56-7 | Reactive Oxygen Species | ||
Riboflavin tetrabutyrate is a lipophilic flavin derivative with antioxidative and lipid peroxide-removing activity. | |||||
| GC30263 | Glucosamine (D-Glucosamine) | 3416-24-8 | Autophagy | ||
Glucosamine (2-amino-2-deoxy-D-glucose) is an amino sugar and a prominent precursor in the biochemical synthesis of glycosylated proteins and lipids. It is commonly used as a treatment for osteoarthritis. Glucosamine(GS) treatment selectively downregulates HIF-1α at the protein level in YD-8 cells via interference of production of the citric acid cycle metabolites. | |||||
| GP26363 | Cor a 8.0101 | - | Allergy | ||
Recombinant Non-specific Lipid-Transfer Protein Cor a 8 produced in SF9 is a glycosylated, polypeptide chain having a calculated molecular mass of 11kDa | |||||
| GP26366 | MALD3 | - | Allergy | ||
Recombinant Non-Specific Lipid-Transfer Protein Mal d 3 produced in SF9 is a glycosylated, polypeptide chain having a calculated molecular mass of 12kDa | |||||
| GP26368 | Tri a 14.0101 | - | Allergy | ||
Recombinant Non-Specific Lipid-Transfer Protein Tri a 14 produced in SF9 is a glycosylated, polypeptide chain having a calculated molecular mass of 13kDa | |||||
| GC39239 | Rifamycin S | 13553-79-2 | Reactive Oxygen Species | ||
Rifamycin S, a quinone and an antibiotic against Gram-positive bacteria (including MRSA), is a clinical drug used to treat tuberculosis and leprosy. Rifamycin S generates reactive oxygen species (ROS) and inhibits microsomal lipid peroxidation. | |||||
| GN10132 | Schizandrin B | 61281-37-6 | Reactive Oxygen Species | ||
A dibenzocyclooctadiene with diverse biological activities | |||||
| GC40408 | Glycerophospho-N-Palmitoyl Ethanolamine | 100575-09-5 | Endocannabinoid/Endocannabinoid-like | ||
Precursor for palmitoyl ethanolamide | |||||
| GC43775 | Glycerophospho-N-Eicosapentaenoyl Ethanolamine | - | Immunology/Inflammation | ||
Precursor for eicosapentaenoyl ethanolamide | |||||
| GC60339 | SKI V | 24418-86-8 | PI3K | ||
SKI V is a noncompetitive and potent inhibitor of non-lipid sphingosine kinase with IC50 of 2 μM for GST-hSK. SKI-V also inhibits PI3K with IC50 of 6 μM for hPI3k. SKI-V decreases formation of the mitogenic second messenger sphingosine-1-phosphate (S1P) and induces apoptosis with antitumor activity. | |||||
| GC41617 | (±)-α-Tocopherol | 10191-41-0 | Lipid Peroxidation | ||
A biologically active form of vitamin E | |||||
| GC46241 | 7-keto Cholesterol-d7 | 127684-08-6 | Atherosclerosis | ||
An internal standard for the quantification of 7-keto cholesterol | |||||
| GC41406 | AMP-Deoxynojirimycin | 216758-20-2 | Gastric Disease | ||
Inhibitor of glucosylceramide synthase and non-lysosomal glucosylceramidase | |||||
| GC19792 | ALC-0315 | 2036272-55-4 | COVID-19 | ||
ALC-0315 是 COVID-19mRNA 疫苗的关键成分,也是核酸治疗研究中备受追捧的脂质。 | |||||
